PARIS & BASEL, Switzerland--(BUSINESS WIRE)--Kyriba Corp., the global leader in cloud-based treasury, cash, risk and payment management solutions, today announced exceptional growth in Switzerland. To strengthen its position as a world leader in the space, Kyriba bolstered its presence in many countries in 2016, including Switzerland. This growth strategy translated into exceptional development of new logos, an increase of +40% from 2015 to 2016.
"The signatures of important new customers in this region in 2016 reinforce our convictions and encourage us to continue our efforts in Switzerland. Recently, Ascensia Diabetes Care, which was established following the acquisition of the Bayer Diabetes Care business by Panasonic Healthcare Holdings and Nova Marine Carriers, the world leader in shipping, joined Kyriba’s community of Swiss customers last year. The community includes Swiss companies such as Bata, COFACE RE, Kepler Cheuvreux, Somfy and Unilabs," says Edi Poloniato, VP Sales & Marketing. "Ascensia Diabetes Care has signed up to use Kyriba’s solution to support their business worldwide."
"We need innovation and technology that can deliver new opportunities for efficiencies and help to benefit our organization," said Jan Vannerum, Chief Financial Officer and Chief Administrative Officer, Ascensia Diabetes Care. "To further streamline our business and enable us to grow faster, we are pleased to bring on fintech leader Kyriba and look forward to the advantages that their system provides through additional cash visibility."
With more than 1,500 corporates using Kyriba’s solution worldwide to optimize the overall visibility of their liquidity, control their currency exposures or the risk of fraud, Kyriba is positioning itself as a credible solution to continue addressing the needs of Swiss companies.
About Kyriba Corp.
Kyriba is the global leader in cloud-based treasury, cash and risk management solutions, delivering Software-as-a-Service (SaaS) financial technology to corporate CFOs and Treasurers. More than 1,500 global organizations use Kyriba to enhance their global cash visibility, improve financial controls, and increase productivity across their cash and liquidity, payments, supply chain finance and risk management operations. Kyriba is headquartered in New York, with offices in San Diego, Paris, London, Tokyo, Singapore, Dubai, Hong Kong, Shanghai and Rio de Janeiro.
To learn how your organization can increase the strategic function of its financial professionals, contact us at firstname.lastname@example.org.
Engage with Kyriba
- Like Kyriba on Facebook at www.facebook.com/kyribacorp
- Follow Kyriba on LinkedIn at www.linkedin.com/company/kyriba-corporation
- Follow Kyriba on Twitter at www.twitter.com/kyribacorp
- Read Kyriba’s blog at www.kyriba.com/blog
About Ascensia Diabetes Care
Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes.
Home to the world-renowned CONTOUR® portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.
Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Ascensia Diabetes Care has around 1,700 employees and operations in 33 countries.
For further information please visit the Ascensia Diabetes Care website at: http://www.ascensia.com.